In this study, we found that MARCH8 is specifically downregulated in breast cancer, especially triple-negative breast cancer, which lacks targeted therapies and frequently metastasizes to distant organs with unfavorable outcomes. This evidence concerns the gene MARCHF8 and breast cancer.